P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI

被引:20
|
作者
Zhang, Liwen [1 ]
Chen, Sheng [2 ]
Liu, Yan [1 ]
Xu, Xueqin [3 ]
Zhang, Qianying [1 ]
Shao, Shuxin [1 ]
Wang, Weiming [1 ]
Li, Xiao [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Nephrol, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gen Surg, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Radiol, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
Lupus nephritis; Hypoxic; Tubulointerstitial fibrosis; BOLD-MRI; ANTAGONIST INCLACUMAB; KIDNEY; EXPRESSION; DISEASE; LESIONS; MODELS; INJURY;
D O I
10.1186/s12967-020-02284-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Lupus nephritis is one of the most common and severe complications of systemic lupus erythematosus, of which poor prognosis is indicated by aggravated renal hypoxia and tubulointerstitial fibrosis. Cell adhesion molecules play a key role in the progression of lupus nephritis tubulointerstitial lesion, including P-selectin, which mediates the rolling of leukocytes and subsequent adhesion and infiltration and then initiates the inflammatory immune response and ischemia and hypoxia injury. However, the effects and mechanisms of P-selectin in lupus nephritis remain to be investigated, and a noninvasive measurement of lupus nephritis tubulointerstitial hypoxia and fibrosis remains to be explored. Methods Thirty-four MRL/lpr mice were randomly divided into the following three groups: MRL/lpr, saline, and anti-P-selectin, which consisted of no treatment, treatment with normal saline, and treatment with anti-P-selectin monoclonal antibody (mAb) from 12 to 16 weeks of age, respectively. Ten male C57BL/6 mice of the same age served as normal controls. 24-h urinary protein, urinary albumin-creatinine ratio, and periodic acid-Schiff were used to assess kidney damage; Western blot or immunohistochemical staining of the hypoxia probe Hypoxyprobe (TM)-1, hypoxia-inducible factor 1 alpha (HIF-1 alpha), and CD31 were used to evaluate hypoxia in renal tissue; and NADPH oxidase subunit gp91phox and p22phox were used to examine renal oxidative stress. The correlation between kidney injury and blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI) was calculated to assess the clinical value of BOLD-MRI. Results P-selectin is upregulated in lupus nephritis. Blocking P-selectin with mAb alleviated renal tubulointerstitial fibrosis, renal hypoxia, and peritubular capillary loss, without alteration of the levels of lupus activity indicators, anti-dsDNA antibody, or complement C3. BOLD-MRI showed that the reduced R2* values in the renal cortex and medulla of lupus mice were increased when treated with anti-P-selectin mAb as compared with those treated with normal saline, which were negatively correlated with Hypoxyprobe (TM)-1 hypoxia probe and the expression of HIF-1 alpha. Conclusions Early intervention of lupus nephritis with anti-P-selectin mAb can significantly improve the hypoxic state of the kidney and reduce the severity of tubulointerstitial lesions. BOLD-MRI techniques are noninvasive and can dynamically evaluate the changes in renal lesions and intrarenal oxygenation levels before and after treatment in lupus nephritis.
引用
收藏
页数:13
相关论文
共 3 条
  • [1] P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI
    Liwen Zhang
    Sheng Chen
    Yan Liu
    Xueqin Xu
    Qianying Zhang
    Shuxin Shao
    Weiming Wang
    Xiao Li
    Journal of Translational Medicine, 18
  • [2] STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis
    Zhu, Jianfen
    Chen, Yijing
    Chen, Yulan
    Lv, Yinqiu
    Chen, Tianxin
    RENAL FAILURE, 2024, 46 (01)
  • [3] 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice
    Xuewei Li
    Jie Liu
    Yingzhe Zhao
    Ning Xu
    E. Lv
    Chunzeng Ci
    Xiangling Li
    BMC Nephrology, 23